Thought Leader

#Trending

Let’s Focus on Lung Health Screening, Not Just Lung Cancer Screening

The guidelines for lung cancer screenings aren’t perfect and will likely continue to evolve, qualifying a more diverse population for screenings. Until then, we must continue to educate our patients, make LDCT accessible, invest in nurse navigators, and make connections between services where they can be most effective.
And if it takes some persistence, so be it. I’d rather talk to a patient about lung cancer screening a dozen times than talk to them once about a lung cancer diagnosis.

Podcasts

A Positive Attitude, a Marathon, and a Mulligan: One Family’s Way to Field a Curve Ball

In the face of a devastating diagnosis of pancreatic cancer, this father-daughter duo share their inspiring story of resilience and advocacy on the OlympusTalks podcast, part of the DeviceTalks platform. Read more about their involvement in the Pancreatic Cancer Action Network, a nonprofit organization that Olympus has partnered with in relation to its endoscopic ultrasound portfolio.

Clinical audience with business professional

Research Round-Up

Healthcare Headwinds and Our Supply Chain Friends

“What’s Going On? Seven Trends on Healthcare Supply Chain Professionals’ Radar,” uncovers some of the myriad issues related to healthcare workforce shortages, supply chain sustainability, quality metrics and more—and includes resources and potential solutions for consideration.

#Trending

InspectTech: The Olympus NDT Podcast from Olympus Scientific Solutions

In this podcast, Emilie Peloquin talks with experts in the nondestructive testing (NDT) field about a variety of topics – from challenging applications to new trends.

Inside Olympus

20 Olympus Voices Bringing Us Into the Roaring '20s

As we venture into a new decade, what is being called the "Roaring '20s" yet again, here are twenty quotes from people who work at Olympus or who have been impacted by Olympus in some way, reminding us of how we touch society and inspiring us for the future.

INVESTOR INFORMATION